Profil

Kuros Biosciences Ltd. operates as biopharmaceutical company, which engages in developing products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals, and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment offers Fibrin-PTH, a drug-biologic combination which promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and by increasing the lifespan of bone-forming cells. The Legacy portfolio segment is involved in all other products that do not belong to the group's core business strategy. The company was founded by Didier Cowling in 2000 and is headquartered in Schlieren, Switzerland.

Staff turnover in EUR2 516 6323 276 4507 337 09020 645 404744 831
Staff turnover in EUR2 516 6323 276 4507 337 09020 645 404744 831
Akcie denominované v EUR20212022202320242025
Akcie v obehu (v miliónoch)3,283,663,6839,412,56
Dividenda na akciu-----
Zisk z podielu bez emisie nových akcií-0,23-0,43-0,38-0,120,06
Prehľad ziskov a strát v miliónoch EUR podľa IAS/IFRS20212022202320242025
Obrat13,818,033,675,6121,3
Prevádzkový zisk (EBIT)-9,6-14,7-14,4-3,54,9
Zisk pred zdanením (EBT)-9,6-16,0-13,3-3,34,2
Annual net profit/ loss-7,5-14,6-13,7-3,72,0
Súvaha v miliónoch EUR IAS/IFRS20212022202320242025
Aktíva
Bežné aktíva celkom32,931,427,244,865,5
Celkové fixné aktíva63,456,648,743,541,7
Celkové aktíva96,388,075,988,3107,2
Záväzky
Celkové krátkodobé záväzky11,312,613,220,933,4
Celkové dlhodobé záväzky8,16,66,08,66,9
Oprávky celkom0,40,00,00,10,0
Základný kapitál77,068,956,758,766,9
Celkové záväzky96,388,075,988,3107,2
Management:
Chris Fair
Florence Barrère de Groot
Katherine Sage
Philippe Saudan
Joost de Bruijn
Daniel Geiger
G. Joseph Ross
John Griffin
Laura Rosa
Marcel Borger
Sjoerd Musters
Predstavenstvo:
Joost de Bruijn
Kimberley Elting
Oliver Walker
Clemens van Blitterswijk
Štruktúra akcionárov v %:
BlackRock Fund Advisors 0,98
BlackRock Investment Management (UK) Ltd. 1,80
C A C M Oomen 24,74
Deka Investment GmbH 1,88
Janus Henderson Investors UK Ltd. 1,16
Joh. Berenberg, Gossler & Co. KG (Investment Management) 2,25
Pegasus Global Opportunity Fund Ltd. 2,70
UBS Asset Management Switzerland AG 2,69
Universal-Investment-Gesellschaft mbH (Invt Mgmt) 2,97
Zürcher Kantonalbank (Investment Management) 1,67
Streubesitz 57,17
Adresa: Wagistrasse 25, 8952 Schlieren
T: +41-44-733-47-47
F: +41-44-733-47-40
I: http://kurosbio.com
E: [email protected]